Read
Listen
Watch
Play
Find
Mail
  • Quotes

  • NAVs

  • News

  • Messages

  • Opinions

  • Notices

  • Videos

Orchid gets nod for Granisetron generic formulation

Published on Thu, Feb 14, 2008 at 15:01 , Updated at Thu, Feb 14, 2008 at 18:30
Source : Moneycontrol.com

Email    Print   

ads by google

Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Granisetron Hydrochloride Tablets. The product is available in 1 mg dosage strength.

 

An anti-emetic product, Granisetron is a new generation non-antibiotic product.

 

With limited generic competition, Orchid hopes to garner a strong market share leading to a sizeable revenue contribution from this product. 

 

Sourced From: Orchid Chemicals & Pharmaceuticals Ltd

Messages on News Now

Post a comment

Other comments

Parsvnath awarded occupancy nod for Greenville project

Could not see the text message..waiting for MMB Messenger views, Training8m, Australia...

in News Now - venkat_c at 07-Oct-08 10:49

No positive news no upward trigger

markets will be down below 10000 soon, exit at cmp, Venkat, Training8m, Queensland, Australia...

in News Now - venkat_c at 07-Oct-08 10:48

More on Messageboard »

Rate this article

Feedback

CNBC TV18 CNN IBN CNBC Awaaz IBN 7 IBN LOKMAT

Chat

Ramesh Damani

Member BSE ,

(08 Oct- 16:30hrs)

What's good investment now?  

Upcoming Chat Schedule »

Previous Chat Transcripts »

Mr Damani's chat is postponed to Wednesday, Oct 8 at 4.30pm

Poll

Where do you see the Nifty bottoming out?

Already bottomed 3400
Below 3200  

Newsletter

Keep in touch with News day & night. Subscribe to:

Mobile Services

Want us to track your stocks 24x7?

Subscribe to our Stock Messaging System

Get news on the move SMS to 52622

  • SMS M for Market News
  • SMS B for Latest Business News
  • SMS S (stock name) for latest news